UCI BIOSAFETY MANUAL

Rev. 2009

   

 

 

Bacillus anthracis

 

University of California, Irvine
Environmental Health and Safety

4600 Health Sciences Road, Irvine, California 92697-2725

(949) 824-6200, Fax (949) 824-8539

_______________________________________

 

Table of Contents


1.0    SCOPE, POLICY AND RESPONSIBILITIES

1.1    Scope

1.1.1        General Applicability

1.1.2        Purpose

1.1.3        Definition of Biohazardous Materials

1.2    Policy

1.3    Responsibilities

1.3.1        Vice Chancellor for Research

1.3.2        Institutional Biosafety Committee (IBC)

1.3.2.1  Charge of the Committee

1.3.2.2  Committee Membership and Procedures

1.3.2.3  Functions of the IBC

1.3.3        Principal Investigator

1.3.3.1  General Responsibilities

1.3.3.2  Submissions of Proposed Work to the Institutional Biosafety Committee (IBC)

1.3.3.3  Prior to Initiating Research

1.3.3.4  During the Conduct of the Research

1.3.4        UCI Biosafety Officer

1.3.4.1  Services to the Laboratories

1.3.4.2  Training Services

1.3.4.3  Institutional Biosafety Committee Support

1.3.4.4  Services on Behalf of the Laboratories

1.3.5        Laboratory Staff

 

2.0    INSTITUTIONAL BIOSAFETY COMMITTEE REVIEW AND APPROVAL PROCESS

 

3.0    BIOSAFETY LEVEL PRACTICES CHART

 

4.0    INFECTIOUS AGENTS

4.1    Infectious Agents and the Lab Worker

4.2    Work with Infectious Agents at UCI

4.2.1        Storage of Infectious Materials

4.2.2        List of Principal Documented Laboratory Acquired Bacterial Infection

4.3    Prions

4.3.1        The Prion Diseases

4.3.2        Modes of Infections
4.3.2.1 Infections Preceded by Overt Personal Accidents
4.3.2.2 Infections not Preceded by Personal Accidents

 

5.0    RECOMBINANT DNA, GENE THERAPY & TRANSGENICS

5.1    Recombinant DNA

5.2    Human Gene Therapy

5.3    Transgenics

5.3.1        Transgenic Animals

5.3.2        Transgenic or Exotic Plants or Pests

 

6.0    BLOODBORNE PATHOGENS, UNIVERSAL PRECAUTIONS, HUMAN TISSUE AND CELL CULTURE

6.1    Definitions

6.2    Bloodborne Pathogens Exposure Control Plan

6.3    Methods of Compliance

6.3.1        Universal Precautions

6.3.2        Engineering & Work Practice Controls

6.3.3        Engineered Sharps Injury Protection

6.3.4        Personal Protective Equipment (PPE)

6.3.5        Housekeeping

6.4    HIV, HBV, or HCV Research Laboratories

6.5    HBV Vaccination & Post-Exposure

6.5.1        General

6.5.2        Hepatitis B Vaccination

6.5.3        Post-Exposure Evaluation & Follow Up

6.5.4        Information to Health Care Provider

6.5.5        Health Care Provider’s Written Opinion

6.6    Hazard Communication

6.6.1        Labels and Signs

6.6.2        Information and Training

6.7    Record Keeping

6.7.1        Medical Records

6.7.2        Training Records

6.7.3        Availability of Records

6.8    Working with Human Tissue

6.8.1        Cell Culture

6.9    Universal Precautions

6.10    Bloodborne Pathogens Exposure Control Plan

 

7.0    USE OF ANIMALS IN RESEARCH

7.1    Disposal of Biohazardous Animals (Campus or Medical Center)

7.2 Transgenic Animals

7.3    Animal Room Safety Information

 

 

8.0    PERSONAL PROTECTIVE EQUIPMENT

8.1    Laboratory

8.1.1        Face Protection

8.1.2        Clothing

8.1.3        Gloves

8.1.4        Respirators

 

9.0  WHOLE BUILDING SAFETY

9.1 Access

9.2 Ventilation

9.3 Plumbing

9.4 Emergency Equipment

                            

10.0  LABORATORY EQUIPMENT

10.1 Biosafety Cabinets

10.1.1    Definition/Funtion

10.1.2    Types of Biosafety Cabinets

10.1.3    Proper Use

10.1.4    Moving/Installation

10.1.5    Decontamination

10.1.6    Certification

10.2 Chemical Fume Hoods

10.3 Centrifuges

10.4 Aerosol-Creating Equipment

10.5 Protection of Vacuum Systems Used in Tissue Culture Work

 

11.0  LABORATORY HOUSEKEEPING

11.1 Practical Custodial Considerations

11.2 Insect/Rodent Control Plan

 

12.0  SIGNS

 

13.0  CLEAN AREAS

 

14.0  LABORATORY MOVES 

14.1 General Guidelines

14.2 Moving the Biosafety Cabinet

 

15.0  BIOHAZARDOUS MATERIAL SPILLS

15.1 Biohazard Spill Cleanup Procedures 

15.1.1    Inside the Biosafety Cabinet (BSC)

15.1.2    In the Lab, Outside the BSC

15.1.3    Inside a Centrifuge

15.1.4    Outside the Lab, In Transit

 

16.0  DECONTAMINATION/DISINFECTIONS

16.1 Definitions

16.2 General Procedures

16.3 Methods

16.3.1    Heat

16.3.2    Liquid Disinfection

16.3.3    Vapors & Gases

16.3.4    Radiation

 

17.0  BIOSAFETY LEVEL-3 LABORATORIES

17.1 General Principles

17.2 Specific Responsibilities, Practices & Procedures

17.2.1    Responsibilities

17.2.2    Information

17.2.3    Personal Protective Equipment

17.2.4    Medical Waste

17.2.5    Decontamination and Housekeeping

17.2.6    Laboratory Maintenance and Repair

17.2.7 Medical Surveillance

17.2.8 Emergencies, Potential Exposures and Spills

 

18.0  LABORATORY INSPECTION

18.1 EH&S Laboratory Building and Safety Survey (LBSS)

18.1.1    Laboratory Identification

18.1.2    Facility/Equipment Review

18.1.3    Work Practices

18.1.4    Hazard Communication

18.1.5    Waste Handling

18.1.6    Interview

18.2 Self-Inspection

18.3 Regulatory Agency Inspection

 

19.0  HANDLING BIOHAZARDOUS AND MEDICAL WASTE 

19.1 Definitions

19.2 Storage & Containment

19.2.1    Storage

19.2.2    Sharps

19.2.3    Transportation

19.2.4    Secondary Containers

19.3 Disposal of Infectious/Biohazardous Waste

19.3.1    Medical Waste

19.3.2    Autoclaving

 

20.0  INFECTIOUS AGENTS AND BIOHAZARDOUS MATERIAL SHIPPING

20.1 Program Description

20.2 Scope of Program

20.3 Definitions

20.4 Responsibilities

20.5 Specific Program Components
20.5.1 Requirements for Biohazardous Materials, Diagnostic Specimens, or Infectious Agents
20.5.2 UCI Requirements for Shipment of Insects
20.5.3 Import/Export Permit Information for Etiologic Agents or Insects
20.5.4 Chemical Shipments

20.6 Reporting Requirements

20.7 Information and External Sources

20.8 Competency and Training Requirements

 

21.0    DHHS-CDC SELECT AGENT AND USDA HIGH CONSEQUENCE LIVESTOCK PATHOGENS

21.1 Exemptions from CDC Select Agent Rule
21.1.1 Medical use of toxins for patient treatment is exempt
21.1.2 If the aggregate amounts
21.1.3 Other exempted agents and toxins

21.2 CDC Select Agent or USDA High Consequence Livestock Pathogens Registration

21.3 Transfer of CDC Select Agents or USDA High Consequence Livestock